Revision as of 19:27, 10 September 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacology|er← Previous edit |
Latest revision as of 07:41, 7 December 2023 edit undoBuidhe (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Template editors136,073 editsm Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot |
(15 intermediate revisions by 15 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
| verifiedrevid = 400110892 |
|
| verifiedrevid = 449583191 |
|
| IUPAC_name = Sodium 5-ethyl-5-hexyl-4,6-dioxo-1H-pyrimidin-2-olate |
|
| IUPAC_name = sodium 5-ethyl-5-hexyl-4,6-dioxo-1H-pyrimidin-2-olate |
|
| image = Sodium_Hexethal.svg |
|
| image = Sodium_Hexethal.svg |
|
| width = 135 |
|
|
|
|
|
|
<!--Clinical data--> |
|
<!--Clinical data--> |
Line 11: |
Line 11: |
|
| pregnancy_category = |
|
| pregnancy_category = |
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_CA = Schedule IV |
|
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
Line 25: |
Line 25: |
|
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number = 144-00-3 |
|
| CAS_number = 144-00-3 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = ATA79U054W |
|
| ATC_prefix = none |
|
| ATC_prefix = none |
|
| ATC_suffix = |
|
| ATC_suffix = |
Line 36: |
Line 39: |
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=12 | H=19 | N=2 | Na=1 | O=3 |
|
| C=12 | H=19 | N=2 | Na=1 | O=3 |
|
| molecular_weight = 262.281 g/mol |
|
|
| smiles = .O=C1/N=C(/)NC(=O)C1(CCCCCC)CC |
|
| smiles = .O=C1/N=C(/)NC(=O)C1(CCCCCC)CC |
|
| InChI = 1/C12H20N2O3.Na/c1-3-5-6-7-8-12(4-2)9(15)13-11(17)14-10(12)16;/h3-8H2,1-2H3,(H2,13,14,15,16,17);/q;+1/p-1 |
|
|
| InChIKey = HXUAXLUDTCGASZ-REWHXWOFAQ |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C12H20N2O3.Na/c1-3-5-6-7-8-12(4-2)9(15)13-11(17)14-10(12)16;/h3-8H2,1-2H3,(H2,13,14,15,16,17);/q;+1/p-1 |
|
| StdInChI = 1S/C12H20N2O3.Na/c1-3-5-6-7-8-12(4-2)9(15)13-11(17)14-10(12)16;/h3-8H2,1-2H3,(H2,13,14,15,16,17);/q;+1/p-1 |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = HXUAXLUDTCGASZ-UHFFFAOYSA-M |
|
| StdInChIKey = HXUAXLUDTCGASZ-UHFFFAOYSA-M |
|
| synonyms = Sodium 5-ethyl-5-hexylbarbiturate, Ortol, Hebaral |
|
| synonyms = Sodium 5-ethyl-5-hexylbarbiturate, Ortal, Hebaral |
|
}} |
|
}} |
|
'''Hexethal''' ('''Ortol''') is a ] derivative invented in the 1940s. It has ] and ] properties, and was used primarily as an anaesthetic in ] medicine. <ref> Butler TC. The rate of penetration of barbituric acid derivatives into the brain. Journal of Pharmacology And Experimental Therapeutics, 1950. 100(2): 219-226 </ref> Hexethal is considered similar in effects to ], with a very fast onset of action but short duration of effects. |
|
'''Hexethal''' ('''Ortal''') is a ] derivative invented in the 1940s. It has ], ], ], and ] properties, and was used primarily as an anaesthetic in ] medicine. |
|
|
<ref>{{cite journal | vauthors = Butler TC | title = The rate of penetration of barbituric acid derivatives into the brain | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 100 | issue = 2 | pages = 219–26 | date = October 1950 | pmid = 14784958 }}</ref> |
|
|
|
|
|
Hexethal is considered similar in effects to ], with a very fast onset of action but short duration of effects. |
|
|
|
|
|
== References == |
|
== References == |
|
|
{{Reflist}} |
|
<references /> |
|
|
|
|
|
|
|
|
|
|
|
{{barbiturates}} |
|
|
|
|
⚫ |
] |
|
|
|
|
|
|
|
{{GABAAR PAMs}} |
|
|
|
|
|
⚫ |
] |
|
{{nervous-system-drug-stub}} |
|
|
|
{{sedative-stub}} |